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Lee, Shin-Da, Chun-Hsien Chu, Erh-Jung Huang, Min-Chi Lu,
Jer-Yuh Liu, Chung-Jung Liu, Hsi-Hsien Hsu, James A. Lin, Wei-
Wen Kuo, and Chih-Yang Huang. Roles of insulin-like growth factor
II in cardiomyoblast apoptosis and in hypertensive rat heart with abdom-
inal aorta ligation. Am J Physiol Endocrinol Metab 291: E306–E314,
2006; doi:10.1152/ajpendo.00127.2005.—Although IGF-II activating the
IGF-II receptor signaling pathway has been found to stimulate cardio-
myocyte hypertrophy, the role of IGF-II in cardiac cell apoptosis remains
unclear. This study aimed to identify the roles of IGF-II and/or IGF-II
receptors (IGF-II/IIR) in cardiomyoblast apoptosis and in hypertensive
rat hearts with abdominal aorta ligation. Cultured rat heart-derived H9c2
cardiomyoblasts and excised hearts from Sprague-Dawley rats with 0- to
20-day complete abdominal aorta ligation, a model of ANG II elevation
and hypertension, were used. IGF-II/IIR expression, caspase activity,
DNA fragmentation, and apoptotic cells were measured by RT-PCR,
Western blot, agarose gel electrophoresis, and TUNEL assay following
various combinations of ANG II, IGF-II/IIR antibody, CsA (calcineurin
inhibitor), SP-600125 (JNK inhibitor), SB-203580 (p38 inhibitor),
U-0126 (MEK inhibitor), or Staurosporine (PKC inhibitor) in H9c2 cells.
ANG II-induced DNA fragmentation and TUNEL-positive cells were
blocked by IGF-II/IIR antibodies and antisense IGF-II, but not by IGF-II
sense. IGF-II-induced apoptosis was blocked by IGF-IIR antibody and
CsA. The increased gene expressions of IGF-II and -IIR induced by ANG
II were reversed by U-0126 and Sp600125, respectively. Caspase 8
activities induced by ANG II were attenuated by U-0126, SP-600125,
and CsA. DNA fragmentation induced by ANG II was totally blocked by
SP-600125, and CsA and was attenuated by U-0126. In rats with 0- to
20-day complete abdominal aorta ligation, the increases in IGF-II/IIR
levels in the left ventricle were accompanied by hypertension as well as
increases in caspase 9 activities and TUNEL-positive cardiac myocytes.
ANG II-induced apoptosis was reversed by IGF-II/IIR blockade and
coexisted with increased transactivation of IGF-II and -IIR, which are
mediated by ERK and JNK pathways, respectively, both of which further
contributed to cardiomyoblast apoptosis via calcineurin signaling. The
increased cardiac IGF-II, IGF-IIR, caspase 9, and cellular apoptosis were
also found in hypertensive rats with abdominal aorta ligation.
angiotensin; apoptosis; growth factor; cardiomyocyte; signal trans-
duction
APOPTOSIS, which is characterized by DNA fragmentation, is
known to increase caspase activities and terminal deoxynucle-
otide transferase-mediated nick end labeling (TUNEL)-posi-
tive cells and could potentially be important in many cardiac
disorders (12, 15). Apoptosis in cardiac cells may be mediated
via a variety of biological signaling pathways, including cal-
cineurin, protein kinase C (PKC), c-Jun NH2-terminal kinase
(JNK), mitogen-activated protein kinase kinase (MEK), p38
mitogen-activated protein kinase (p38), and extracellular sig-
nal-regulated kinase/mitogen-activated protein kinase (ERK-
MAPK) pathways (23). An elevation in angiotensin II (ANG
II) level is commonly observed in cardiovascular diseases,
including hypertension, coronary artery disease, left ventricular
hypertrophy, and heart failure (17). There is a growing body of
evidence suggesting that ANG II functions as a regulator of
apoptosis in cardiac cells (12). Most of the evidence indicates
that the stimulation of ANG II in the heart is associated with an
increased rate of myocardial apoptosis (9, 16). Although the
mechanism of apoptosis enhanced by ANG II is still contro-
versial due to a variety of possible pathways, the calcium-
calcineurin pathway has been regarded as an important one for
ANG II-induced apoptosis in cardiac cells (14, 19, 21). ANG II
has been shown to activate calcineurin through Gq/PLC
signaling transduction. Calcineurin is mediated by permeabil-
ity transition pore formation and activates the mitochondrial
apoptotic pathway (21). The activations of JNK, ERK, and p38
pathways may be responsible for ANG II-induced cardiac cell
hypertrophy (3), whereas the roles of ERK, JNK, PKC, and
p38 in ANG II-induced cardiomyoblast apoptosis remain con-
troversial.
Cardiac myocytes express relatively high levels of IGF-II
after ischemia induced by occlusions and reperfusion of the left
anterior descending coronary artery (20). In addition to binding
with the IGF-II receptor (IGF-IIR), IGF-II can bind with the
insulin receptor A subtype and IGF-IR (24). When IGF-II
activates the IGF-IIR signaling pathway, IGF-II might activate
calcineurin through Gi protein signaling transduction and stim-
ulate cardiac cell hypertrophy (2, 18). To our knowledge,
however, it is still unclear whether relatively high levels of
IGF-II stimulate cardiomyocyte apoptosis. Calcium-cal-
cineurin has been shown to dephosphorylate proapoptotic
Bcl-2 family protein-Bad and to induce cytochrome c release
from the mitochondria to the cytosol, which may further induce
caspase activities and apoptosis (7). However, it is still un-
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known whether calcineurin is involved in the role of IGF-II in
cardiomyocyte apoptosis. It is also unclear whether ANG II
regulates IGF-II/IIR signalings and further activates calcium-
calcineurin or other pathways in cardiac cell apoptosis.
Although an elevation in ANG II level and an increase in
blood pressure have been reported in an animal model with a
complete abdominal aorta ligation (1), we do not know
whether IGF-II/IIR expressions and cardiac apoptotic activity
would be increased in a similar context. In this study, we
hypothesize that ANG II-induced cardiomyoblast apoptosis is
regulated by IGF-II/IIR systems via the calcium-calcineurin
pathway and that the cardiac IGF-II system and cardiac apop-
tosis are induced by complete abdominal aorta ligation.
ANG II-induced apoptosis has been found in cultured car-
diomyoblast H9c2 cells and in hearts excised from a hyperten-
sive rat model with abdominal aorta ligation. We found that the
ANG II-induced apoptosis in cardiomyoblast H9c2 was atten-
uated by IGF-II or IGF-IIR blockade and that ANG II-induced
apoptosis coexisted with upregulation of IGF-II and IGF-IIR.
The upregulated IGF-II and IGF-IIR were mediated by the
ERK and JNK pathways, respectively, both of which further
contribute to cardiomyocyte apoptosis via calcineurin signal-
ing. In addition, the increased IGF-II, IGF-IIR, caspase 9
activities, and cellular apoptosis were also found in the hearts
excised from hypertensive rats with abdominal aorta ligation.
METHODS
Cell Culture
H9c2 cardiomyoblast cells were obtained from American Type
Culture Collection (ATCC) and were cultured in Dulbecco’s modified
essential medium supplemented with 10% fetal bovine serum, 2 mM
glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, and 1 mM
pyruvate in humidified air (5% CO2) at 37°C. H9c2 cells were
cultured in serum-free medium for 12 h and then treated with or
without ANG II (108 M; Sigma Chemical, St. Louis, MO), antisense
IGF-II (14 M), sense IGF-II (14 M), IGF-II antibody (100 ng/ml;
Neo Markers, Fremont, CA), or IGF-IIR antibody (100 ng/ml; Santa
Cruz Biotechnology, Santa Cruz, CA). The incubation was continued
for another 24 h, and then the cells were harvested and extracted for
analysis.
Animal Preparation
Sixty-seven male Sprague-Dawley rats were purchased from the
National Laboratory Animal Breeding and Research Center, Taipei,
Taiwan. Ambient temperature was maintained at 25  1°C, and the
animals were kept on an artificial 12:12-h light-dark cycle from 7 AM
to 7 PM. Rats were provided with standard laboratory chow (Lab Diet
5001; PMI Nutrition International, Brentwood, MO) and water ad
libitum. Under pentobarbital sodium (1 ml/kg) anesthesia, all animals
were processed by either sham operation or complete ligation of the
abdominal aorta between the two origins of the renal arteries. The rat
with ligation of the abdominal aorta was a well-developed animal
model with an elevation in ANG II level, systemic hypertension, and
cardiac hypertrophy. Thus, after ligation on 0 day (sham, n  8), 1
day (sham, n 4 vs. ligation, n 4), 2 days (sham, n 5 vs. ligation,
n  5), 3 days (sham, n  7 vs. ligation, n  6), 5 days (sham, n 
3 vs. ligation, n 3), 7 days (sham, n 4 vs. ligation, n 4), 10 days
(sham, n  4 vs. ligation, n  4), and 20 days (sham, n  3 vs.
ligation, n  3), systolic, diastolic, and mean arterial blood pressures
were determined with a sphygmomanometer (29SSP; IITC/Life Sci-
ence Instruments) in all rats. Then, these animals were killed, and the
hearts were removed for the further analysis. All protocols were
approved by the Institutional Animal Care and Use Committee of
Chung Shan Medical University and conformed to the Guide for the
Care and Use of Laboratory Animals published by the US National
Institutes of Health.
Design and Synthesis of IGF-II Oligonucleotides and Transfection
The 15-mers of IGF-II antisense oligonucleotides and sense oligo-
nucleotides used in this study target the translation initiation site of
IGF-II mRNAs of the rats, and antisense IGF-II oligonucleotides were
complementary to nucleotides (5-ATG GGG ATC CCA GTG-3). In
addition, the IGF-II sense oligonucleotides were the same as nucleo-
tides (5-ATG GGG ATC CCA GTG-3) used as negative control.
The sequences had no similarity to other mammalian genes. All
antisense and sense oligonucleotides were synthesized as lyophilized
powders and reconstituted in sterile, nuclease-free Tris-EDTA buffer
(10 mM Tris HCl, 1 mM EDTA, pH 7.4; MDBio, Taipei, Taiwan)
and were stored at 20°C. Cells were grown to 80% confluence in
100-mm dishes. IGF-II oligonucleotides and Lipofectamine were
separately diluted in serum-free DMEM to 200-l volumes, mixed,
and incubated at room temperature for 20 min. Cells were washed
twice with PBS and overlaid with 5 ml of serum-free DMEM, to
which the DNA lipid complexes were added. The cells were incubated
for 6 h at 37°C, whose medium was replaced with DMEM-10% FBS,
and harvested after 24 h.
TUNEL
After various treatments, H9c2 cells were fixed with 4% parafor-
maldehyde solution for 30 min at room temperature. After a rinse with
phosphate-buffered saline (PBS), the samples were first incubated
with phalloidin-rhodamine for 1 h and with TUNEL reaction mixture
containing terminal deoxynucleotidyl transferase and fluorescein iso-
thiocyanate-dUTP (Roche Applied Science, Indianapolis, IN). In heart
tissues, the 3-m-thick paraffin sections were deparaffinized by im-
mersion in xylene, rehydrated, and incubated in PBS with 2% H2O2 to
inactivate endogenous peroxidases. Next, the sections were incubated
with proteinase K (20 g/ml), washed in PBS, and incubated with
terminal deoxynucleotidyl transferase for 90 min and fluorescein
isothiocyanate-dUTP for 30 min at 37°C using an apoptosis detection
kit (Roche Applied Science). Then, the sections were stained with
4,6-diamidino-2-phenylindole to detect cell nucleus by UV light
microscopic observations (blue). Samples were analyzed in a drop of
PBS under a fluorescence and UV light microscope at this state,
respectively, using an excitation wavelength in the range of 450–500
nm and detection in the range of 515–565 nm (green). The number of
TUNEL-positive cardiac myocytes was determined by counting 3 
105 cardiac myocytes. All morphometric measurements were per-
formed by at least two individuals independently in a blinded manner.
DNA Fragmentation
H9c2 cells were lysed in 50 l of lysis buffer (50 mM Tris HCl,
pH 7.4, 20 mM EDTA, 1% Igepal-630) followed by incubation with
1% SDS and 5 g/l RNase (Roche Molecular Biochemicals, Mann-
heim, Germany) for 2 h at 56°C and 2.5 g/l proteinase K (Roche) for
2 h at 37°C, and only fragmented DNAs were extracted. DNAs were
ethanol precipitated and finally resuspended in distilled water. The
fragmented DNAs were electrophoretically fractionated on a 1.5%
agarose gel and stained with ethidium bromide.
Inhibitors
H9c2 cells were treated with several inhibitors, including SB-
203580 (p38 MAP kinase inhibitor; Promega), CsA (calcineurin
inhibitor), U-0126 (MEK1 and MEK2 inhibitor; Promega),
SP-600125 (JNK inhibitor; Promega), LY-294002 (PI 3-kinase inhib-
itor; Promega), and Staurosporine (PKC inhibitor). The final concen-
trations of inhibitors were 10 M in SB-203580, 1 M in CsA, 30
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M in U-0126, 20 M in SP-600125, 10 M in LY-294002, and 20
M in Staurosporine.
Total RNA Extraction
Total RNA was extracted using the Ultraspec RNA isolation
System (Biotecx Laboratories, Houston, TX) according to directions
supplied by the manufacturer. Respectively, H9c2 cells and cardiac
tissues were thoroughly homogenized (1 ml Ultraspec reagent/100 mg
tissue cell) with a homogenizer. The RNA precipitate was washed
twice by gentle vortexing with 70% ethanol, collected by centrifuga-
tion at 12,000 g, dried under vacuum for 5–10 min, dissolved in
50–100 l of diethylpyrocarbonate-treated water, and incubated for
10–15 min at 55–60°C.
Reverse Transcription and PCR Amplification
cDNA was prepared in a buffer containing 50 mM Tris HC1, pH
8.5, 30 mM KCl, 8 mM MgCl, 1 mM dithiothreitol, 0.25 mM each
dCTP, dGTP, dTTP, and dATP, 20 U of recombinant ribonuclease
inhibitor, 1 pg of random hexamers, 5 pg of total RNA, and 40 U of
avian myeloblastosis virus reverse transcriptase in a volume of 20 pl.
This mixture was incubated for 10 min at room temperature followed
by 1 h at 42°C to initiate cDNA synthesis. This mixture was then used
for amplification of specific cDNAs by PCR. The buffer for PCR
contained 50 mM KCI, 10 mM Tris HC1, pH 8.3, at 20°C, 0.2 mM
each dCTP, dGTP, dTMP, and dATP, 0.5 pM oligonucleotide PCR
primers, 2.5 U of Taq polymerase, and various MgCl concentrations
in a final volume of 100 pl. Following the hot start (5 min at 95°C,
80°C hold), the samples were subjected to 35 cycles of 45 s at 95°C,
2 min at 52°C, and 45 s at 72°C. For the IGF-II, IGF-IIR, and GAPDH
primers, the primer annealing temperature was 56°C. This was fol-
lowed by a final extension step at 72°C for 10 min. All RNA samples
used were demonstrated to have intact 18S and 28S RNA bands on
ethidium bromide-strained formaldehyde-agarose gels. Primers were
as follows: rat IGF-II forward primer CTTGTTGACACGCTTCAGT,
reverse primer GTTCACTGATGGTTGCTGGA; rat IGF-IIR forward
primer GCAAGGGCATAAAGGTGAA, reverse primer TGTAAGT-
Fig. 1. ANG II-induced cardiomyoblast apop-
tosis in H9c2 cells was attenuated by IGF-II
antibody, IGF II receptor (IGF-IIR) antibody,
and antisense IGF-II. Representive DNA
fragmentation and cellular apoptosis (re-
peated 3 times) was measured by 1.5% aga-
rose gel electrophoresis, and TUNEL assay
was used in cardiomyoblast H9c2 cells cul-
tured in serum-free medium for 12 h and then
treated with IGF-II antibody (IGF-II Ab, 100
ng/ml) or IGF-IIR antibody (IGF-IIR Ab,
100 ng/ml) and antisense IGF-II (14 M) or
sense IGF-II (14 M) for 1 h and then treated
with ANG II (108 M) or ANG II alone for
48 h.
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CACCCTGTGCAA; rat GAPDH forward primer TCCCTCAAGAT-
TGTCAGCAA, reverse primer AGATCCACAACGGATACA TT
(MDBio, Taipei, Taiwan).
Protein Extraction and Western Blot Analysis
Cultured H9c2 cells were scraped and washed once with PBS. Cell
suspension was then spun down, and cell pellets were lysed for 30 min
in lysis buffer [50 mM Tris, pH 7.5, 0.5 M NaCl, 1.0 mM EDTA, pH
7.5, 10% glycerol, 1 mM basal medium Eagle, 1% Igepal-630, and
proteinase inhibitor cocktail tablet (Roche)] and spun down 12,000
rpm for 10 min. Then, the supernatants were applied to new Eppen-
dorf tubes for Western blot analysis. The protein extracts from the
heart of rats with a complete ligation of the abdominal aorta were
prepared by homogenizing the left ventricle samples in a PBS buffer
(0.14 M NaCl, 3 mM KCl, 1.4 mM KH2PO4, 14 mM K2HPO4) at a
concentration of 40 g tissue/20 l PBS for 5 min. The homogenates
were placed on ice for 10 min and then centrifuged at 12,000 rpm for
30 min. The supernatant was collected and stored at70°C for further
Western experiments. Proteins from the H9c2 cell line or animal heart
extracts were then separated in 12% gradient SDS-PAGE and trans-
ferred to nitrocellulose membranes. Nonspecific protein binding was
blocked in blocking buffer (5% milk, 20 mM Tris HCl, pH 7.6, 150
mM NaCl, and 0.1% Tween 20) and blotted with specific antibodies
of caspase 8, caspase 9, IGF-II, IGF-IIR, and -tubulin (Santa Cruz
Biotechnology) as indicated for each experiment in the blocking
buffer at 4°C overnight. Densitometric analysis of immunoblots or
PCR was performed using the AlphaImager 2200 digital imaging
system (Digital Imaging System, San Leandro, CA).
Protocols
Protocol 1. To investigate whether ANG II-induced cardiomyo-
blast apoptosis is IGF-II system dependent, DNA fragmentation and
apoptosis were measured by agarose gel electrophoresis and TUNEL
assay in cardiomyoblast H9c2 cells treated with IGF-II antibody (100
ng/ml), IGF-IIR antibody (100 ng/ml), antisense IGF-II (14 M), and
sense IGF-II (14 M) for 1 h and then treated with ANG II (108 M)
for 48 h.
Protocol 2. To clarify whether and what pathways ANG II upregu-
lates the IGF-II/IIR gene expressions, IGF-II/IIR RNAs were mea-
sured by RT-PCR in H9c2 cells pretreated with one of signaling
pathway inhibitors individually, including SP-600125 (JNK inhibi-
tor), CsA (calcineurin inhibitor), SB-203580 (p38 inhibitor), U-0126
Fig. 2. Gene expressions of IGF-II and IGF-
IIR induced by ANG II were mediated via
ERK and JNK pathways, respectively, in H9c2
cells. A: representative amount of IGF-II and
IGF-IIR gene expression (repeated 3 times)
from extracted RNA were measured by RT-
PCR in H9c2 cells cultured in serum-free (SF)
medium for 12 h and then treated with one of
the signaling pathway inhibitors individually,
including CsA (calcineurin inhibitor),
SP-600125 (SP, JNK inhibitor), SB-203580
(SB, p38 inhibitor), U-0126 (U, MEK inhibi-
tor), or LY-294002 (LY, PI 3-kinase inhibitor).
After 2 h, H9c2 cells were further treated with
ANG II for 24 h. A relative quantification on
the basis of GAPDH was applied. B: bars
represent the relative quantification of IGF-II
and IGF-IIR measured by densitometric anal-
ysis on the basis of day 0 and indicate mean
values  SE (repeated 3 times). *P  0.05,
significant differences from SF; #P  0.05,
significant differences from ANG II.
E309IGF-II AND ANG II IN CARDIAC APOPTOSIS
AJP-Endocrinol Metab • VOL 291 • AUGUST 2006 • www.ajpendo.org
(MEK inhibitor), LY-294002 (PI 3-kinase inhibitor), and further
treated with ANG II.
Protocol 3. To clarify what pathways ANG II induces apoptotic
activity, DNA fragmentation was measured by agarose gel electro-
phoresis in H9c2 cells pretreated with one of the signaling pathway
inhibitors, including SP-600125 (JNK inhibitor), CsA (calcineurin
inhibitor), SB-203580 (p38 inhibitor), U-0126 (MEK inhibitor), and
Staurosporine (PKC inhibitor) for 2 h and further treated with ANG II
for 24 h.
Protocol 4. To clarify what pathways ANG II activates, proapop-
totic protein caspase 8 and caspase 9 activity was measured by
Western Blot analysis in H9c2 cells pretreated with one of the
signaling pathway inhibitors individually, including SP-600125 (JNK
inhibitor), CsA (calcineurin inhibitor), SB-203580 (p38 inhibitor),
U-0126 (MEK inhibitor), and LY-294002 (PI 3-kinase inhibitor) for
2 h and further treated with ANG II for 24 h.
Protocol 5. To investigate whether the IGF II system and apopto-
sis-related proteins were upregulated in an animal model with ele-
vated ANG II and hypertension, the mRNA expression and protein
products of IGF-II/IIR and caspase 9 protein extracted from the left
ventricle of excised hearts in 6-wk-old Sprague-Dawley rats with
complete abdominal aorta ligation for 0, 1, 2, 3, 5, 7, 10, and 20 days
were measured by RT-PCR and Western blot analysis.
Protocol 6. To investigate whether cardiac apoptosis occurs in an
animal model with elevated ANG II and hypertension, cardiac tissues
stained with TUNEL assay were measured in 6-wk-old Sprague-
Dawley rats with complete abdominal aorta ligation for 0, 10, and 20
days.
Statistics
The blood pressures were compared between sham and ligation
groups of animals from day 0 to day 20 using one-way analysis of
variance (ANOVA) with preplanned contrast comparison against
control level at the same day of postsurgery. Densitometric analysis of
immunoblots or PCR in bar figures (Figs. 2, C and D, 4C, and 5C)
were analyzed via ANOVA with preplanned contrast comparison
against the control group (serum free) or against the ANG II group.
The percentage of TUNEL-positive cardiac myocytes (Fig. 6B) were
analyzed via ANOVA with preplanned contrast comparison against
control level (day 0). In all cases, a difference at P  0.05 was
considered statistically significant. All data presented in the text and
figures are means  SE.
RESULTS
ANG II-Induced DNA Fragmentation Is Attenuated
by Blocking the IGF-II System
ANG II-induced DNA fragmentation was markedly attenu-
ated by IGF-II antibody, IGF-IIR antibody (Fig. 1A), or anti-
sense IGF-II, but not by sense IGF-II (Fig. 1B). ANG II-
induced H9c2 cellular apoptosis measured by TUNEL assay
was attenuated by IGF-II antibody, IGF-IIR antibody, or anti-
sense IGF-II, but not by sense IGF-II (Fig. 1C).The findings in
Fig. 1 suggest that ANG II-induced cardiomyoblast apoptosis
was attenuated by blocking the IGF-II system.
Gene Expressions of IGF-II/IIR Induced by ANG II Were
Mediated via ERK and JNK Pathways, Respectively, in
H9c2 Cells
RT-PCR revealed an increase in the expression of IGF-II
gene (Fig. 2A) and IGF-IIR gene (Fig. 2B) in H9c2 cells after
administration of ANG II (108 M). The amount of gene
expression in IGF-II and IGF-IIR was significantly increased
by pretreatment of ANG II only (Fig. 2). ANG II-induced
IGF-II gene overexpression was not attenuated by CsA, SB-
203580, or LY-294002, but was attenuated by U-0126 (Fig. 2,
A and C). ANG II-induced IGF-IIR gene overexpression was
not attenuated by CsA, SB-203580, U-0126, or LY-294002,
but was attenuated by SP-600125 (Fig. 2, B and D). The
findings in Fig. 2 suggest that ANG II-induced IGF-II and
IGF-IIR gene overexpression in cardiomyoblast was mainly
via the ERK and JNK pathways, respectively.
ANG II-Induced Apoptosis in H9c2 Cells Was Activated
by JNK, ERK, and Calcineurin Pathways
The increased DNA ladder formation revealed that cardio-
myoblast H9c2 cells undergoing DNA fragmentation upon
exposure to ANG II (108 M) was markedly attenuated by
SP-600125 and CsA, and it was partially attenuated by U-0126
but was not attenuated by SB-203580, Staurosporine, or LY-
294002 compared with the serum-free negative control (Fig.
3). The findings in Fig. 3 suggest that ANG II-induced
cardiomyoblast apoptosis is mediated mainly by the JNK
and calcineurin pathways and partially mediated by the ERK
pathway.
ANG II-Induced Caspase 8 and Caspase 9 in H9c2 Cells
Was Mediated by JNK, ERK, and Calcineurin Pathways
Compared with the serum-free negative control, the ac-
tivity of the active form of caspase 8 (Fig. 4A) and caspase
9 (Fig. 4B) was increased, but the proform of caspase 8 (Fig.
4A) was decreased after administration of ANG II (108 M).
Fig. 3. Possible pathways associated with ANG II-induced DNA fragmenta-
tion in H9c2 cardiomyoblasts. Representative DNA fragmentation (repeated 3
times) was measured by 1.5% agarose gel electrophoresis in cardiomyoblast
H9c2 cells cultured in serum-free medium for 12 h and then treated with ANG
II (108 M) alone or ANG II plus one of signaling pathway inhibitors
individually, including SP-600125 (JNK inhibitor), CsA (calcineurin inhibi-
tor), SB-203580 (p38 inhibitor), U-0126 (MEK inhibitor), or Staurosporine
(PKC inhibitor, 10 M) for 24 h.
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The increased activity of activated caspase 8 induced by
ANG II was not affected by SB-203580 or LY-294002 but
was attenuated by SP-600125, CsA, and U-0126 (Fig. 4, A
and C). The increased caspase 9 activity induced by ANG II
was not affected by SB-203580, U-0126, or LY-294002 but
was attenuated by SP-600125 and CsA (Fig. 4, B and C).
The findings in Fig. 4 suggest that ANG II-induced caspase
8 activity is mediated mainly by the JNK, calcineurin, and
ERK pathways, whereas ANG II-induced caspase 9 activity
Fig. 4. Signaling pathways of caspase 8 and caspase 9 induced by ANG II in
H9c2 cardiomyoblast cells. A and B: representative protein products of pro-
form and active form of caspase 8 and caspase 9 (repeated 3 times) were
measured by Western blotting analysis in H9c2 cells cultured in serum-free
medium for 12 h and then treated with one of the signaling pathway inhibitors
individually, including SP-600125, CsA (calcineurin inhibitor), SB-203580
(p38 inhibitor), U-0126 (MEK inhibitor), and LY-294002 (PI 3-kinase inhib-
itor). After 2 h, H9c2 cells were further treated with ANG II (108 M) for 24 h.
Relative quantification on the basis of -tubulin (40 g) was applied. C: bars
represent relative quantification of active-form caspases 8 and 9 to -tubulin
on the basis of control group (serum free) and indicate mean values  SE
(repeated 3 times). *P  0.05, different from serum-free group; #P  0.05,
significant differences from ANG II group.
Fig. 5. Mean arterial blood pressure in rats with complete abdominal aorta
ligation and IGF-IIR, IGF-II, and caspase 9 in hearts. A: mean arterial blood
pressure (MABP) in 6-wk-old Sprague-Dawley rats with either sham or
complete abdominal aorta ligation for 0, 1, 2, 3, 5, 7, 10, or 20 days were
measure by tail cuff. *P 0.05 significant difference between sham group and
ligation group. B: gene expressions of IGF-II and IGF-IIR extracted from left
ventricles of excised hearts in rats with complete abdominal aorta ligation from
days 0–20 were measured by RT-PCR. Relative quantification on the basis of
GAPDH was applied. C: protein products of activated caspase 9, IGF-II, and
IGF-IIR extracted from left ventricles of excised hearts in rats with complete
abdominal aorta ligation from days 0–20 were measured by Western blotting
analysis. Relative quantification on the basis of -tubulin was applied. D: bars
represent relative quantification of IGF-II, IGF-IIR, and activated caspase 9 on
the basis of day 0 and indicate mean values  SE (repeated 3 times). *P 
0.05, significant differences from day 0.
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is mainly mediated by the JNK and calcineurin pathways
(Fig. 4C).
IGF-II, IGF-IIR, Caspase 9 Activity, and Mean Arterial
Blood Pressure Were Increased in Rats with Complete
Abdominal Aorta Ligation
Systolic blood pressure (not shown), diastolic blood pressure
(not shown), and mean arterial blood pressure were all signif-
icantly increased following days 2, 3, 5, 7, 10, and 20 and
reached a plateau at day 5 after complete abdominal aorta
ligation compared with sham (Fig. 5A). The time-dependent
increases in IGF-II/IIR gene expressions and protein products
in the left ventricle were accompanied by an increase in
activated caspase 9 protein levels and increased mean arterial
blood pressure following days 5, 7, 10, and 20 of complete
abdominal aorta ligation. On the 20th day of ligation, IGF-II/
IIR levels and caspase 9 activity both reached the highest
levels. The percentage of TUNEL-positive cardiac myocytes in
hearts excised from rats with complete abdominal aorta liga-
tion was significantly increased on day 10 and day 20 com-
pared with that on day 0 (sham). The findings in Fig. 6 suggest
that, in the rats with complete abdominal aorta ligation, the
increased levels of IGF-II and IGF-IIR in the left ventricle
were accompanied by increases in caspase 9 activities and
apoptosis after ligation.
DISCUSSION
Our main findings can be summarized as follows. 1) ANG
II-induced DNA fragmentation and cellular apoptosis were
markedly attenuated by IGF-II antibody, IGF-IIR antibody,
and antisense IGF-II, but not by sense IGF-II, in H9c2 cells
(Fig. 1). 2) The increased gene expressions of IGF-II and
IGF-IIR induced by ANG II were markedly attenuated by
U-0126 (MEK inhibitor) and SP-600125 (JNK inhibitor), re-
spectively (Fig. 2). 3) DNA fragmentation and activated
caspase 8 activity induced by ANG II were also attenuated by
U-0126 (MEK inhibitor), SP-600125 (JNK inhibitor), and CsA
(calcineurin inhibitor) in H9c2 cells, whereas activated caspase
9 activity induced by ANG II was only attenuated by SP-
600125 (JNK inhibitor) and CsA (calcineurin inhibitor) (Figs.
3 and 4). 4) In the hypertensive rats with complete abdominal
aorta ligation, the time-dependent increases in the gene expres-
sion and the protein levels of IGF-II and IGF-IIR in the left
ventricles were accompanied by increases in activated caspase
9 activity, TUNEL-positive cardiac cell apoptosis, and blood
pressure. In addition, the levels of IGF-II and IGF-IIR, the
Fig. 6. A: total cells and apoptotic cells of excised
hearts in 6-wk-old Sprague-Dawley rats with com-
plete abdominal aorta ligation on days 0, 10, and 20
were stained with 4,6-diamidino-2-phenylindole
(DAPI) (top, blue spots) and TUNEL assay (bottom,
green spots), respectively. B: bars represent the per-
centage of TUNEL-positive cardiac myocytes on the
basis of total cells stained with DAPI and indicate
mean values  SE (repeated 3 times). *P  0.05,
significant differences from day 0.
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level of activated caspase 9, and the number of cardiac
TUNEL-positive cells reached much higher levels on the 20th
day after ligation (Fig. 5). To our knowledge, this study is the
first time to identify the roles of IGF II and IIR in ANG
II-induced cardiomyoblast apoptosis and in rat heart with
abdominal aorta ligation. After integrating the current findings,
we summarized the roles of IGF-II in ANG II-induced car-
diomyoblast apoptosis and in rat heart with abdominal aorta
ligation in Fig. 7.
ANG II markedly increased DNA fragmentation, caspase 8 activ-
ity, caspase 9 activity, and the number of TUNEL-positive cells in
cardiomyoblast H9c2 cells. In addition, the increased caspase 9
activity and TUNEL-positive apoptosis were also found in the rat
hearts with elevation of ANG II and blood pressure. These findings
suggest that ANG II induces cardiomyoblast and cardiac cell apop-
tosis. ANG II appears to be able to induce apoptosis in diverse
cellular types and to be a deliberate form of cell death involved in the
pathogenesis of various cardiovascular diseases, including heart fail-
ure and vascular remodeling (4). ANG II has been reported to be
involved in the stimulation of cardiac apoptosis in essential hyper-
tension (9, 16). Apoptosis has been found to be preceded by increases
in tissue ANG II but not in plasma ANG II concentrations in canine
models of congestive heart failure (6). Therefore, the effects of ANG
II on cardiac cells may be critical in the development of cardiovas-
cular diseases and hypertension. The current study not only confirms
that ANG II induces cardiomyoblast apoptosis but also reveals the
IGF-II-related pathways for ANG II-induced cardiac apoptosis, a
matter of great scientific interest.
In the current study, because ANG II-induced apoptotic DNA
fragmentation and apoptosis in cardiomyoblast H9c2 cells appear
to be attenuated by antisense IGF-II, IGF-II antibody, and IGF-IIR
antibody, we can speculate whether IGF-II with its downstream
pathway activation may play a fundamental role in ANG II-
induced cardiomyoblast apoptosis and cause DNA fragmentation.
Surprisingly, when IGF-II and IGF-IIR were blocked, the delete-
rious action of ANG II appeared to be greatly suppressed in
cardiomyoblast apoptosis. To our knowledge, this study is the first
to report the inhibitory roles of IGF-II blockade and IGF-IIR
antibody in ANG II-induced apoptosis in cardiac cells.
Because IGF-II and IGF-IIR play a critical role in ANG
II-induced apoptosis in cardiomyoblast cells, it was critical to
know whether ANG II would modulate the IGF-II system via
certain signaling pathways. Our second major finding was that
ANG II did upregulate the gene expressions of IGF-II and
IGF-IIR and that the ANG II-induced the gene expressions of
IGF-II and IGF-IIR were markedly attenuated by U-0126
(MEK inhibitor) and SP-600125 (JNK inhibitor), respectively.
We can speculate that ANG II upregulates IGF-II gene expres-
sion by activating the ERK pathway, whereas ANG II upregu-
lates IGF-IIR gene expression by activating the JNK pathway.
To our knowledge, this is the first report showing that IGF-II
and IGF-IIR are upregulated by ANG II via the ERK and JNK
pathways, respectively, in cardiomyoblast cells.
DNA fragmentation, caspase 8 activity, caspase 9 activity, and
cellular apoptosis induced by ANG II were attenuated by CsA
(calcineurin inhibitor) in H9c2 cells, suggesting that ANG II-
induced cardiomyoblast apoptosis was mediated not only by the
IGF-II system described above but also by calcineurin-dependent
pathways. As was found in our study, calcineurin inhibitor has
been shown to inhibit ANG II-induced apoptosis in endothelial
cells, suggesting that calcineurin inhibitor has a general apopto-
sis-suppressive effect (25). Because the unregulated gene expres-
sions of IGF-II and IGF-IIR induced by ANG II were markedly
attenuated by U-0126 (MEK inhibitor) and SP-600125 (JNK
inhibitor), respectively, we wondered whether ANG II-induced
apoptosis would be mediated by upregulation of the IGF-II system
via ERK and JNK signaling pathways. In the current study, DNA
fragmentation and caspase 8 activity induced by ANG II were also
attenuated by SP-600125 (JNK inhibitor), by CsA (calcineurin
inhibitor), and partially by U-0126 (MEK inhibitor) in H9c2 cells,
whereas caspase 9 activities induced by ANG II were attenuated
only by SP-600125 (JNK inhibitor) and CsA (calcineurin inhibi-
tor) (Figs. 3 and 4). In other words, after blocking IGF-IIR and the
JNK pathway, activated caspase 8 and caspase 9 apoptotic protein
levels were both attenuated, but after blocking IGF-II and the
MEK pathway, only activated caspase 8 (not activated caspase 9)
was attenuated. In addition, when calcineurin was blocked, the
effects of ANG II were largely inhibited. IGF-IIR is a multifunc-
tional single-transmembrane glycoprotein that has been shown to
bind both IGF-II and mannose 6-phosphate (8). If the action of
IGF-II is blocked, another IGF-IIR ligand, mannose 6-phosphate,
or other ligands may also have some unknown effects on IGF-IIR,
possibly explaining why blockade of IGF-II decreases only
caspase 8 (not caspase 9), unlike the blockade of IGF-IIR. How-
ever, very little is known about the physiological significance of
mannose 6-phosphate on IGF-IIR in the function of the cardio-
vascular system. In sum, ANG II appears to upregulate IGF-II and
IGF-IIR via the ERK and JNK signaling pathways, respectively,
and further activates caspase 8 and caspase 9 via calcineurin-
dependent pathways.
In the current study, the time-dependent increases in the gene
expressions and protein products of IGF-II and IGF-IIR in the left
ventricle were accompanied by an increase in activated caspase 9
Fig. 7. Possible roles and pathways of IGF-II and IGF-IIR in ANG II-induced
cardiomyoblast and in hypertensive rats with abdominal aorta ligation. ANG
II-induced cardiomyoblast apoptosis was reversed by blockades of IGF-IIR
signaling such as IGF-II blockade and IGF-IIR blockade. ANG II-induced
cardiomyoblast apoptosis coexisted with increased transactivation of IGF-II
and IGF-IIR, which are mediated by ERK and JNK pathways, respectively,
both of which further contribute to cardiomyoblast apoptosis via calcineurin
signaling. Additionally, the findings in the ANG II-elevated and hypertensive
animal models with complete abdominal aorta ligation partially support our
hypothesis and show that ANG II upregulated IGF-II and IGF-IIR expression
and induced activated caspase 9-related apoptotic activities in rat hearts.
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protein levels and TUNEL-positive cardiomyocytes following
0–20th day of complete abdominal aorta ligation, suggesting that
the IGF II system and apoptotic activity are upregulated in animal
models with elevated ANG II and hypertension. The findings in
the animal models that we used support our current findings that
ANG II induced caspase 9 activities and cellular apoptosis and
that ANG II upregulated the gene expression of IGF-II and
IGF-IIR in cardiac cells and rat hearts. The increase of plasma
ANG II and the changes of myocardial tissues have been previ-
ously reported in the rat model with abdominal aortic ligation
around the aorta above and below the renal arteries (5, 10). In
another previous study, abdominal aortic ligation increased the
ratio of heart weight-to-body weight 	22% and increased apop-
totic cardiocytes after 2 wk, suggesting that pressure overload
coexisting with elevated ANG II may contribute to chronic hy-
pertrophy and cardiocyte apoptosis in rat hearts (22). One study
has mentioned that the transcript levels for IGF-II and their
associated cell surface receptors were increased in banded supra-
renal abdominal aorta of 5-day-old rat pups during the early
neonatal periods of heart development (11). This indirectly sup-
ports our findings that the upregulation of the gene expressions
and protein products of IGF-II and IGF-IIR in the hearts excised
from rats with complete abdominal aorta ligation.
Significance in Clinical Application
Prior to our studies, very limited information was available
about how IGF-II and IGF-IIR contribute to ANG II-induced
cardiac apoptosis. ANG II has been found to play a critical role
in controlling cardiovascular and renal homeostasis, whereas
unbalanced (overactivated) ANG II is known to contribute to
cardiovascular diseases such as hypertension, atherosclerosis,
and heart failure (13). Our findings may provide direct evi-
dence that myocardial cell death in cardiovascular patients in
coexistance with an elevation of ANG II level might be caused
by an upregulation of the IGF-II system via the ERK and JNK
signaling pathways and calcineurin activity.
With regard to therapeutic application, our findings may further
propose that cardiovascular patients should normalize ANG II
function in cardiac tissues, such as by applying ANG II inhibitor
and angiotensin-converting enzyme (ACE) inhibitor as well as
proposing that cardiovascular patients should prevent an upregu-
lation of the IGF-II system and calcineurin activity, such as by
applying IGF-II, IGF-IIR, or calcineurin inhibitors to supress
cardiac apoptosis. Of course, further studies are required to clarify
the possible clinical intervention related to the mechanism of the
IGF-II system in the ANG II-induced cardiac apoptosis.
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